Research Papers:
Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 1521 views | HTML 3016 views | ?
Abstract
Bothina Al-Harbi1, Siti-Fauziah Hendrayani1, Gabriela Silva1,2 and Abdelilah Aboussekhra1
1Department of Molecular Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
2Current/Present address: Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal
Correspondence to:
Abdelilah Aboussekhra, email: [email protected]
Keywords: breast cancer; let-7b; cancer-associated fibroblasts; IL-8
Received: November 26, 2017 Accepted: February 27, 2018 Published: April 03, 2018
ABSTRACT
Cancer-associated fibroblasts (CAFs) are major players in the development and spread of breast carcinomas through non-cell-autonomous signaling. These paracrine effects are under the control of several genes and microRNAs. We present here clear evidence that let-7b, a tumor suppressor microRNA, plays key roles in the persistent activation of breast stromal fibroblasts and their functional interplay with cancer cells. We have first shown that let-7b is down-regulated in CAFs as compared to their corresponding normal adjacent fibroblasts, and transient specific let-7b inhibition permanently activated breast fibroblasts through induction of the IL-6-related positive feedback loop. More importantly, let-7b-deficient cells promoted the epithelial-to-mesenchymal transition process in breast cancer cells in an IL-8-dependent manner, and also enhanced orthotopic tumor growth in vivo. On the other hand, overexpression of let-7b by mimic permanently suppressed breast myofibroblasts through blocking the positive feedback loop, which inhibited their paracrine pro-carcinogenic effects. Furthermore, we have shown that let-7b negatively controls IL-8, which showed higher expression in the majority of CAF cells as compared to their adjacent normal counterparts, indicating that IL-8 plays a major role in the carcinoma/stroma cross-talk. These findings support targeting active stromal fibroblasts through restoration of let-7b/IL-8 expression as a therapeutic option for breast carcinomas.

PII: 24895